Assignee
MBRACE THERAPEUTICS INC
US·0 granted patents·5 pending applications·0 citations·filing 2023–2025
Top patents by PatentIndex Score
5 records- 0165US2023416798A1Methods of recombinant antibody production and related cell systemsMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0263US2024068004A1Cell-free methods of producing antibodies to intracellular targetsMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0363US2024010714A1Cell-free methods of recombinant antibody productionMBRACE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0442US2025255980A1Antibody-Drug Conjugates Against the Glucose-regulating Protein 78 (GRP78)MBRACE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0541US2025302984A1Antibody-Drug Conjugates Against EPH Receptor A5 (Epha5) for Treatment of CarcinomaMBRACE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →